Yamamoto A, Takaichi S, Hara H, Nishikawa O, Yokoyama S, Yamamura T, Yamaguchi T
Atherosclerosis. 1986 Dec;62(3):209-17. doi: 10.1016/0021-9150(86)90095-x.
Effects of probucol on lipid storage in macrophages in vitro in the presence of acetylated low density lipoprotein (acetyl-LDL) were observed using macrophage-like cells (UE-12) established from a human histiocytic lymphoma cell line (U-937). Under ordinary light microscopy as well as under electron microscopy we found that probucol added to the medium, either in ethanolic solution or bound to LDL, markedly prevented the development of macrophages into foam cells. Microscale enzymatic assay of cholesterol also showed that the intracellular accumulation of esterified cholesterol caused by acetyl-LDL was markedly decreased by the addition of probucol. The concentration of probucol added to the medium was almost comparable to the plasma concentration of the drug usually obtained in patients under treatment with probucol. The possibility that probucol interferes with the binding of acetyl-LDL to the receptors on the cell surface was suggested. The results of the present investigation coincide with the clinical findings that probucol causes a more marked regression of xanthomas than would be expected from the extent of lowering of LDL cholesterol.
使用从人组织细胞淋巴瘤细胞系(U - 937)建立的巨噬细胞样细胞(UE - 12),观察了普罗布考在体外乙酰化低密度脂蛋白(乙酰 - LDL)存在下对巨噬细胞脂质储存的影响。在普通光学显微镜以及电子显微镜下,我们发现添加到培养基中的普罗布考,无论是乙醇溶液形式还是与低密度脂蛋白结合的形式,都能显著阻止巨噬细胞转变为泡沫细胞。胆固醇的微量酶法测定也表明,添加普罗布考可显著降低由乙酰 - LDL引起的细胞内酯化胆固醇的积累。添加到培养基中的普罗布考浓度几乎与接受普罗布考治疗的患者通常获得的血浆药物浓度相当。这提示了普罗布考可能干扰乙酰 - LDL与细胞表面受体结合的可能性。本研究结果与临床发现一致,即普罗布考使黄瘤消退的程度比预期的由低密度脂蛋白胆固醇降低程度所导致的更为明显。